68 related articles for article (PubMed ID: 20571909)
21. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
[TBL] [Abstract][Full Text] [Related]
22. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
Harbers M; Wahlström GM; Vennström B
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
[TBL] [Abstract][Full Text] [Related]
23. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
[TBL] [Abstract][Full Text] [Related]
24. Modulation of expression of RA-regulated genes by the oncoprotein v-erbA.
Ventura-Holman T; Mamoon A; Subauste JS
Gene; 2008 Dec; 425(1-2):23-7. PubMed ID: 18775481
[TBL] [Abstract][Full Text] [Related]
25. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
[TBL] [Abstract][Full Text] [Related]
26. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
[TBL] [Abstract][Full Text] [Related]
27. Activins and activin antagonists in hepatocellular carcinoma.
Deli A; Kreidl E; Santifaller S; Trotter B; Seir K; Berger W; Schulte-Hermann R; Rodgarkia-Dara C; Grusch M
World J Gastroenterol; 2008 Mar; 14(11):1699-709. PubMed ID: 18350601
[TBL] [Abstract][Full Text] [Related]
28. Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.
Kallwitz ER; McLachlan A; Cotler SJ
World J Gastroenterol; 2008 Jan; 14(1):22-8. PubMed ID: 18176957
[TBL] [Abstract][Full Text] [Related]
29. Large-scale analysis by SAGE reveals new mechanisms of v-erbA oncogene action.
Bresson C; Keime C; Faure C; Letrillard Y; Barbado M; Sanfilippo S; Benhra N; Gandrillon O; Gonin-Giraud S
BMC Genomics; 2007 Oct; 8():390. PubMed ID: 17961265
[TBL] [Abstract][Full Text] [Related]
30. Thyroid hormone responsive genes in the murine hepatocyte cell line AML 12.
Ventura-Holman T; Mamoon A; Maher JF; Subauste JS
Gene; 2007 Jul; 396(2):332-7. PubMed ID: 17532580
[TBL] [Abstract][Full Text] [Related]
31. Anti-apoptotic effects of 3,5,3'-tri-iodothyronine in mouse hepatocytes.
Sukocheva OA; Carpenter DO
J Endocrinol; 2006 Nov; 191(2):447-58. PubMed ID: 17088414
[TBL] [Abstract][Full Text] [Related]
32. Deregulation of the activin/follistatin system in hepatocarcinogenesis.
Grusch M; Drucker C; Peter-Vörösmarty B; Erlach N; Lackner A; Losert A; Macheiner D; Schneider WJ; Hermann M; Groome NP; Parzefall W; Berger W; Grasl-Kraupp B; Schulte-Hermann R
J Hepatol; 2006 Nov; 45(5):673-80. PubMed ID: 16935389
[TBL] [Abstract][Full Text] [Related]
33. A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.
Roberts DM; Anderson AL; Hidaka M; Swetenburg RL; Patterson C; Stanford WL; Bautch VL
Mol Cell Biol; 2004 Dec; 24(24):10515-28. PubMed ID: 15572660
[TBL] [Abstract][Full Text] [Related]
34. NDRG2 expression and mutation in human liver and pancreatic cancers.
Hu XL; Liu XP; Lin SX; Deng YC; Liu N; Li X; Yao LB
World J Gastroenterol; 2004 Dec; 10(23):3518-21. PubMed ID: 15526377
[TBL] [Abstract][Full Text] [Related]
35. The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value.
Iino S; Abeyama K; Kawahara K; Yamakuchi M; Hashiguchi T; Matsukita S; Yonezawa S; Taniguchi S; Nakata M; Takao S; Aikou T; Maruyama I
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6179-88. PubMed ID: 15448005
[TBL] [Abstract][Full Text] [Related]
36. Alterations of the M6p/Igf2 receptor gene in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats.
Tsujiuchi T; Sasaki Y; Oka Y; Kuniyasu H; Konishi Y; Tsutsumi M
Mol Carcinog; 2004 Apr; 39(4):199-205. PubMed ID: 15057872
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators.
Yu Y; Khan J; Khanna C; Helman L; Meltzer PS; Merlino G
Nat Med; 2004 Feb; 10(2):175-81. PubMed ID: 14704789
[TBL] [Abstract][Full Text] [Related]
38. Expression of activins C and E induces apoptosis in human and rat hepatoma cells.
Vejda S; Erlach N; Peter B; Drucker C; Rossmanith W; Pohl J; Schulte-Hermann R; Grusch M
Carcinogenesis; 2003 Nov; 24(11):1801-9. PubMed ID: 12949049
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of activin beta(C) or activin beta(E) in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of hepatic cells.
Chabicovsky M; Herkner K; Rossmanith W
Endocrinology; 2003 Aug; 144(8):3497-504. PubMed ID: 12865331
[TBL] [Abstract][Full Text] [Related]
40. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
Gavrilova O; Haluzik M; Matsusue K; Cutson JJ; Johnson L; Dietz KR; Nicol CJ; Vinson C; Gonzalez FJ; Reitman ML
J Biol Chem; 2003 Sep; 278(36):34268-76. PubMed ID: 12805374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
